Immune to Cancer: The CRI Blog

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
awards and honors checkpoint inhibitors combination therapy adoptive cell therapy cancer immunotherapy clinical accelerator conferences dendritic cells clinical trials aacr

AACR18: Day 4 Update

April 18, 2018Arthur N. Brodsky, Ph.D.
Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and others’ efforts to overcome resistance to PD-1 therapy as well as insights into the role of dendritic cells.

Read More

Filter by:
Subscribe

Recent Posts
conference vaccines checkpoint inhibitors CAR T cells aacr

AACR17 Update: CAR T Cells, Tregs, and the Future of Immunotherapy

Arthur N. Brodsky, Ph.D.
April 02, 2017
conference checkpoint inhibitors pancreatic cancer brain cancer aacr

AACR17 Update: Taking Immunotherapy to the Next Level

Arthur N. Brodsky, Ph.D.
April 01, 2017
conference

Immunotherapy at AACR 2017 Annual Meeting

Arthur N. Brodsky, Ph.D.
March 31, 2017
lymphoma fda approval checkpoint inhibitors blood cancers childhood cancer

Pembrolizumab Approved for Children and Adults with Hard-to-Treat Hodgkin Lymphoma

Arthur N. Brodsky, Ph.D.
March 15, 2017
checkpoint inhibitors colorectal cancer

How Immunotherapy Offers Hope for Colorectal Cancer Patients

Arthur N. Brodsky, Ph.D.
March 08, 2017
Top